JUser: :_load: Unable to load user with ID: 474

Freeport-McMoRan Inc (FCX) Pops 3.57% for November 21

Equities Staff |

One of the S&P 500’s big winners for Friday November 21 was Freeport-McMoRan Inc (FCX) as the company’s stock climbed 3.57% to $29.59 on volume of 17.1 million shares.

The stock opened at $29.75 and saw an intraday low of $29.25 and an intraday high of $29.92. All told, the day saw a per-share gain of $1.02. The stock’s average daily volume of 10.36 million and 1.04 billion shares outstanding. Freeport-McMoRan Inc now has a 50-day SMA is $30.50 and 200-day SMA is $33.24, and it has a 52-week high of $39.32 and a 52-week low of $27.07.

Freeport-McMoRan Inc, formerly Freeport-McMoRan Copper & Gold, deals in the mining of copper, gold and molybdenum.

Based out of Phoenix, AZ, Freeport-McMoRan Inc has 36100 employees and, after today’s trading, reached a market cap of $30.75 billion. The stock’s P/E Ratio is 13.1. Its P/S ratio is 1.34, P/B ratio is 1.42, and P/FCF ratio is -75.6.

For a full analysis of Freeport-McMoRan Inc, check out Equities.com’s E.V.A. report for Freeport-McMoRan Inc.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
FCX Freeport-McMoRan Inc. 14.13 -0.78 -5.23 66,063,595


Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…